A pathological complete response after immunotherapy with pembrolizumab for distal duodenal adenocarcinoma caused by Lynch syndrome: a case report-Reference-Cited by-同舟云学术

A pathological complete response after immunotherapy with pembrolizumab for distal duodenal adenocarcinoma caused by Lynch syndrome: a case report

Published:2023-07-26 Issue:4 Volume:12 Page:279-284
ISSN:2192-3183
Container-title:International Cancer Conference Journal
language:en
Short-container-title:Int Canc Conf J

Author:

Ikeda Shinichiro,Hu Qingjiang^ORCID,Natsugoe Keita,Harima Tomoya,Tanaka Yasushi,Kinoshita Izumi,Nonaka Kentaro,Nambara Sho,Nakanishi Ryota,Nakanoko Tomonori,Ota Mitsuhiko,Kimura Yasue,Oki Eiji,Oda Yoshinao,Yoshizumi Tomoharu

Publisher

Springer Science and Business Media LLC

Subject

General Earth and Planetary Sciences,General Environmental Science

Link

https://link.springer.com/content/pdf/10.1007/s13691-023-00622-w.pdf

Reference18 articles.

1. Yasuda S, Harada S, Tsujimoto A et al (2019) A pathological complete response by chemotherapy with S-1 and oxaliplatin for a locally advanced duodenal adenocarcinoma in Lynch syndrome: a case report. Surg case Rep 5(1):146

2. Nishikawa Y, Hoshino N, Horimatsu T et al (2020) Chemotherapy for patients with unresectable or metastatic small bowel adenocarcinoma: a systematic review. Int J Clin Oncol 25(8):1441–1449

3. Hirashita T, Ohta M, Tada K et al (2018) Prognostic factors of non-ampullary duodenal adenocarcinoma. Jpn J Clin Oncol 48(8):743–747

4. Alicia L, Preethi S, Yelena K et al (2019) Microsatellite Instability Is Associated With the Presence of Lynch Syndrome Pan-Cancer. J Clin Oncol 37(4):286–295

5. Akagi K, Oki E, Taniguchi H et al (2021) Real-world data on microsatellite instability status in various unresectable or metastatic solid tumors. Cancer Sci 112(3):1105–1113